Indefinite Delivery Contract SPE2DX16D3903

The federal contract IDV award, SPE2DX16D3903, is an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.00, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

This single-award IDC serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver essential pharmaceutical and medical supplies to DLA facilities supporting the Department of Defense worldwide. The contract has an ultimate completion date of November 23, 2023. Amerisourcebergen Drug Corp also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential healthcare commodities to serve the needs of military personnel, veterans, and other federal beneficiaries.